𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer

✍ Scribed by Elaine M. Smith; Michael Pawlita; Linda M. Rubenstein; Thomas H. Haugen; Eva Hamsikova; Lubomir P. Turek

Publisher
John Wiley and Sons
Year
2009
Tongue
French
Weight
201 KB
Volume
127
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

High‐risk human papillomavirus types (HPV‐HR) are associated with head and neck cancer (HNC) risk and better survival. Most patients with HPV‐HR DNA‐positive tumors develop anti‐HPV E6/E7 antibodies; however, it is unclear whether those who mount an immune response have similar risk factors or clinical outcomes as those who do not. HPV‐16 DNA tumor‐positive HNC cases were evaluated for HPV‐16 E6 and E7 antibodies using a GST capture ELISA system. Among 57 HPV‐16 DNA tumor‐positive HNC cases, 67% were detected with HPV‐16 E6 and/or E7 antibodies. Male gender (76% vs. 42%, p = 0.02), younger age (63% vs. 16%, p = 0.001) but not tobacco or alcohol were associated with E6 and/or E7 seropositivity. Seropositivity was associated more often with late stage (76%), poor grade (65%), positive nodes (82%). and in the oropharynx (82%), Median disease‐specific and recurrence‐free survival were longer in E6 and/or E7 seropositive compared to E6/E7‐negative cases (2.2 years vs. 1.4 years, both outcomes), although results were not statistically significant. When examined jointly with p16 expression, E6 and/or E7‐positive/p16‐positive cases had better disease‐specific (2.1 years vs. 1.1 years, p = 0.06) and recurrence‐free (2.3 years vs. 1.1 years, p = 0.03) survival compared to E6‐/E7‐/p16‐ cases. These findings suggest there are 2 distinct HNC patient groups with HPV DNA‐positive tumors, distinguishable by E6 and/or E7 antibody status. Differences in antibody status are associated with distinct risk factors and clinical outcomes. This information can be available as a simple blood test at initial presentation, before the removal of tissue through biopsy or surgery.

📜 SIMILAR VOLUMES

Antibodies against oncoproteins E6 and E
Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma
✍ Klaus Zumbach; Markus Hoffmann; Tomas Kahn; Franz Bosch; Stefan Gottschlich; Tib 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 69 KB 👁 1 views

Human papillomaviruses (HPVs) have been recognized as an essential pathogenic factor in anogenital cancer. HPV DNA has also been found in a subgroup of head-and-neck squamous-cell carcinomas (HNSCCs), and a causative role of the virus in the development of these tumors has been suggested by the conc

Antibodies against human papillomavirus
Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: Correlation with presence of papillomavirus DNA
✍ Ricardo Rosales; Mario López-Contreras; Roberto Risco Cortes 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 1 views

## Abstract Human papillomavirus (HPV) infection is associated with cervical cancer. The E2 and E1 papillomavirus proteins are expressed at the early stage of infection and regulate DNA replication. The E2 protein activates and represses transcription from different HPVs promoters. At some stage wh

Tumor necrosis factor-α promotes human p
Tumor necrosis factor-α promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin-dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway
✍ Darci Gaiotti; Jean Chung; Maite Iglesias; Matthias Nees; Patricia D. Baker; Cha 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

Tumor necrosis factor-a (TNF-a) inhibits growth of normal cervical keratinocytes but stimulates proliferation of human papillomavirus (HPV)±immortalized and cervical carcinoma±derived cell lines when mitogens such as epidermal growth factor (EGF) or serum are depleted. Current work identifies the me

A manual of human anatomy. In five volum
A manual of human anatomy. In five volumes. Vols. I–IV: By J. T. Aitken, M.D., Reader in Anatomy at University College, London; G. Causey, M.B., F.R.C.S., Professor of Anatomy, Royal College of Surgeons, London; J. Joseph, M.D., M.R.C.O.G., Reader in Anatomy, Guy's Hospital, London; and J. Z. Young, M.A., F.R.S., Professor of Anatomy, University College, London. Vol. V: By J. T. Aitken; D. A. Sholl, B.Sc., Reader in Anatomy, University College, London; and J. Z. Young. 8 1/2 × 5 1/2 in. Vol. I, Thorax and Upper Limb. Pp. 162 + viii, with 36 illustrations. 14s. Vol. II, Head and Neck. Pp. 180 + viii, with 53 illustrations. 16s. Vol. III, Abdomen and Pelvis. Pp. 135 + viii, with 29 illustrations. 12s. 6d. Vol. IV, Lower Limb. Pp. 117 + viii, with 36 illustrations. 12s. 6d. Vol. V, Central Nervous System. Pp. 140 + viii, with 40 illustrations. 1956–7. Edinburgh: E. & S. Livingstone Ltd. 12s. 6d
📂 Article 📅 1958 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 2 views